InnoGene Co

InnoGene Co Tangible Book Value per Share

The Tangible Book Value per Share of InnoGene Co (344860.KQ) as of Oct 15, 2026 is 1,386.39 KRW. In the previous year, Tangible Book Value per Share was 1,340.21 KRW — a change of 3.45% (higher).

Tangible Book Value per Share

1,386.39KRW

YoY

3.45%

Last updated:

Tangible Book Value per Share of InnoGene Co is 2024 1,386.39 KRW. Tangible Book Value per Share of InnoGene Co was 2023 1,340.21 KRW. It decreases by 3.45% higher compared to the previous year.

The InnoGene Co Tangible Book Value per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Tangible Book Value per Share
Date
Tangible Book Value per Share
Jan 1, 2018
217.25 KRW
Jan 1, 2019
191.44 KRW
Jan 1, 2020
259.66 KRW
Jan 1, 2021
450.54 KRW
Jan 1, 2022
563.77 KRW
Jan 1, 2023
1,340.21 KRW
Jan 1, 2024
1,386.39 KRW
The InnoGene Co Tangible Book Value per Share history
YEARTangible Book Value per ShareYoY
1,386.39KRW+3.45%
1,340.21KRW+137.72%
563.77KRW+25.13%
450.54KRW+73.51%
259.66KRW+35.64%
191.44KRW-11.88%
217.25KRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

InnoGene Co Stock analysis

What does InnoGene Co do? InnoGene Co Ltd is a company based in Seoul, South Korea, operating within the Consumer Staples sector and the Consumer products industry. The company has 77 employees and went public on April 27, 2020. Its website is http://www.innogene.com/. InnoGene focuses on research and development related to skin regeneration and anti-aging solutions, utilizing stem cell technology and fusion technology. The company develops and manufactures cosmetics aimed at skin regeneration and aging control. Additionally, InnoGene is involved in the manufacturing and distribution of medical devices. The company's primary activities revolve around creating products that address skin health and aging concerns, leveraging scientific research in stem cell applications. As a publicly traded entity, InnoGene operates under the ticker symbol 344860.KQ and is registered with the ISIN KR7344860002. The company's headquarters are located in Seoul, and it serves a market that values innovative skincare and medical device solutions. InnoGene's product portfolio includes both cosmetic and medical device offerings, targeting consumers interested in advanced skincare technologies. The company's operations are centered on research-driven development to enhance skin health and combat aging effects. InnoGene Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about InnoGene Co stock

Tangible Book Value per Share of InnoGene Co is 1,386.39 KRW in 2024.

Tangible Book Value per Share of InnoGene Co changed from 1,340.21 KRW to 1,386.39 KRW, representing a 3.45% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Tangible Book Value per Share InnoGene Co since 2006 – with annual values, charts, and detailed analysis.

Tangible book value per share excludes intangible assets and goodwill, providing a more conservative measure of per-share net asset value.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — InnoGene Co

All Key Metrics — InnoGene Co